Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefit and Tolerability of a Probiotic Product in Subjects With Increased Susceptibility to Common Cold

NCT02013934 is registered in ClinicalTrials.gov with Probi AB as lead sponsor.

NCT NCT02013934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02013934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefit and Tolerability of a Probiotic Product in Subjects With Increased Susceptibility to Common Cold
Lead sponsor
Probi AB
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2013
Completion date
May 17, 2016
Enrollment
899 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

viral infections of the upper respiratory tract